Garrison Bradford & Associates’s Johnson & Johnson JNJ Stock Holding History

Garrison Bradford & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,229	Closed	-$254K	–	39
2025 Q4	$254K	Hold	1,229	–	–	0.28%	28
2025 Q3	$228K	Hold	1,229	–	–	0.24%	29
2025 Q2	$188K	Hold	1,229	–	–	0.21%	31
2025 Q1	$204K	Buy	+1,229	New	+$192K	0.22%	28
2024 Q2	–	Sell	-1,345	Closed	-$213K	–	31
2024 Q1	$213K	Hold	1,345	–	–	0.22%	28
2023 Q4	$211K	Hold	1,345	–	–	0.23%	29
2023 Q3	$209K	Sell	1,345 -505	-27%	-$83.3K	0.25%	29
2023 Q2	$306K	Hold	1,850	–	–	0.37%	28
2023 Q1	$287K	Hold	1,850	–	–	0.36%	31
2022 Q4	$327K	Hold	1,850	–	–	0.4%	31
2022 Q3	$302K	Buy	1,850 +150	+9%	+$25.4K	0.37%	31
2022 Q2	$302K	Hold	1,700	–	–	0.34%	35
2022 Q1	$301K	Hold	1,700	–	–	0.29%	44
2021 Q4	$291K	Hold	1,700	–	–	0.26%	45
2021 Q3	$275K	Hold	1,700	–	–	0.28%	46
2021 Q2	$280K	Hold	1,700	–	–	0.29%	42
2021 Q1	$279K	Hold	1,700	–	–	0.31%	42
2020 Q4	$268K	Hold	1,700	–	–	0.33%	40
2020 Q3	$253K	Hold	1,700	–	–	0.36%	39
2020 Q2	$239K	Hold	1,700	–	–	0.35%	39
2020 Q1	$223K	Hold	1,700	–	–	0.38%	40
2019 Q4	$248K	Hold	1,700	–	–	0.31%	45
2019 Q3	$220K	Hold	1,700	–	–	0.3%	43
2019 Q2	$237K	Sell	1,700 -2,000	-54%	-$277K	0.28%	49
2019 Q1	$517K	Hold	3,700	–	–	0.44%	42
2018 Q4	$477K	Hold	3,700	–	–	0.43%	43
2018 Q3	$511K	Hold	3,700	–	–	0.41%	40
2018 Q2	$449K	Hold	3,700	–	–	0.37%	41
2018 Q1	$474K	Hold	3,700	–	–	0.4%	38
2017 Q4	$517K	Hold	3,700	–	–	0.43%	36
2017 Q3	$481K	Hold	3,700	–	–	0.4%	36
2017 Q2	$489K	Hold	3,700	–	–	0.42%	39
2017 Q1	$461K	Sell	3,700 -150	-4%	-$17.9K	0.41%	42
2016 Q4	$444K	Hold	3,850	–	–	0.41%	44
2016 Q3	$455K	Hold	3,850	–	–	0.43%	44
2016 Q2	$467K	Sell	3,850 -100	-3%	-$11.4K	0.46%	40
2016 Q1	$427K	Hold	3,950	–	–	0.5%	41
2015 Q4	$406K	Hold	3,950	–	–	0.45%	44
2015 Q3	$369K	Hold	3,950	–	–	0.41%	52
2015 Q2	$385K	Hold	3,950	–	–	0.38%	56
2015 Q1	$397K	Hold	3,950	–	–	0.37%	59
2014 Q4	$413K	Buy	3,950 +700	+22%	+$73.8K	0.37%	58
2014 Q3	$346K	Hold	3,250	–	–	0.35%	65
2014 Q2	$340K	Hold	3,250	–	–	0.32%	69
2014 Q1	$319K	Hold	3,250	–	–	0.31%	71
2013 Q4	$298K	Hold	3,250	–	–	0.28%	69
2013 Q3	$282K	Hold	3,250	–	–	0.29%	70
2013 Q2	$279K	Buy	+3,250	New	+$276K	0.3%	70

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garrison Bradford & Associates's JNJ Position: Q1 2026 in Review

Garrison Bradford & Associates sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,229 shares — an estimated $254K sold.

Garrison Bradford & Associates first reported a position in JNJ in Q2 2013 and held it in 48 quarters. The position peaked at $517K in Q1 2019. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Garrison Bradford & Associates reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Garrison Bradford & Associates sold 1,229 Johnson & Johnson shares in Q1 2026, an estimated $254K.
Garrison Bradford & Associates first reported a position in Johnson & Johnson in Q2 2013 and held it in 48 quarters.
Garrison Bradford & Associates's Johnson & Johnson position peaked at $517K in Q1 2019.
4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Garrison Bradford & Associates's 13F filing for Q1 2026, filed 4 May 2026.